Search Results 331-340 of 17332 for Proto-oncogene

  1. https://www.mayoclinic.org/spanish_organization_concepts.xml

  2. A Phase I Study of MSB2311 in Advanced Solid Tumors - Mayo Clinic

    This is a phase I study to determine the safety and toxicity, PK/PD, immunogenicity, biomarkers, anti-tumor activity and establish a preliminary recommended ...

  3. A Study of the Performance of Genome Sequencing as a Clinical Test to Identify Multifocal Lung Cancers for Treatment, versus Advanced Metastatic Disease

    The purpose of this study is to assess the use and performance of a genome sequencing test to identify multifocal lung cancer tumors, which can be treated with ...

  4. Open-label Study of the Safety and Activity of Oprozomib in Patients With Hematologic Malignancies - Mayo Clinic

    The purpose of this study is to determine the maximum tolerated dose (MTD), activity, and safety of oprozomib in patients with hematologic malignancies.

  5. Germ cell tumors - Doctors and departments - Mayo Clinic

    Learn about these tumors that form from reproductive cells. Explore treatment options, including surgery, chemotherapy and radiation therapy.

  6. Nasal and paranasal tumors - Doctors and departments - Mayo Clinic

    Learn about these cancerous and noncancerous growths that form in and around the nose. Treatments include surgery, radiation and chemotherapy.

  7. Colorectal Cancer - eMERGE Genome Informed Risk Assessment - Mayo Clinic Research

    EPCAM. MLH1. MSH2. MSH6. STK11. PMS2. For participants with monogenic risk, the GIRA report recommends referral to a genetic counselor.

  8. Germ cell tumors - Doctors and departments - Mayo Clinic

    Learn about these tumors that form from reproductive cells. Explore treatment options, including surgery, chemotherapy and radiation therapy.

  9. Iobenguane I-131 Or Crizotinib And Standard Therapy In Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma Or Ganglioneuroblastoma - Mayo Clinic

    Patients with ALK aberrant tumors (ALK tyrosine kinase mutation or ALK amplification) will be non-randomly assigned to receive crizotinib added to current COG ...

  10. Why Choose Mayo Clinic for Cancer Treatment

    The first thing to do when a patient is diagnosed is I tell that patient, this is a scary moment. We understand that. Take a deep breath. As you come to see me ...